Provider comparison builder
Choose up to three evaluated GLP-1 programs and see every rubric criterion side by side: the 0 to 3 score, the one-line reason, the evaluation date, and where the programs differ most. Editorial scores from public pages, not user reviews; the conflict disclosure travels with every view and every copy.
Read this before you compare
These are editorial scores from each company's public pages on the date shown, not user reviews and not ratings. FormBlends, which runs this site, operates a competing compounded GLP-1 program and is scored on the same rubric with the conflict marked. A higher total is not a recommendation. Compounded GLP-1s are not FDA approved. Details: conflict of interest and the rubric.
Pick up to 3 providers
0 of 3 selected. Each one links to its full evaluation.
Rubric rows, side by side
Choose one to three providers on the left. The table shows each rubric criterion with the score and the one-line reason from the evaluation.
Formulashown in full, nothing hidden
score(criterion) = the level (0, 1, 2 or 3) whose written definition matches the public pages on the evaluation date total = sum of the eight criterion scores, out of 24 no weighting: every criterion counts the same, so the rows matter more than the total gap(criterion) = max(score) minus min(score) across the selected providers; rows with a gap of 2 or more are listed first
Each score comes from the evaluation page for that provider, where the one-line reason is expanded with the page it came from and the date it was read. The level definitions are on the rubric page. If a company changes a page, the score changes at the next re-check, not before.
Assumptions, checked September 4, 2026
- Rubric version 1.0, published 2026-09-04. Scores are editorial assessments from public pages, not user reviews, not ratings, not a recommendation.
- Every provider was scored by the same editorial team, including FormBlends, which runs this site and sells a competing compounded GLP-1 program. That conflict is disclosed on every evaluation page and in the copied text.
- A score describes what a company publishes, not the quality of its clinical care. A program can publish little and treat patients well; the rubric cannot see that.
- Compounded semaglutide and tirzepatide are not FDA approved and are not interchangeable with Wegovy, Ozempic, Zepbound or Mounjaro. Brand-only programs score on the same rows.
- Prices and terms change. The evaluation date on each column is the date the pages were read.
This calculator is an arithmetic aid for medication a licensed prescriber has already prescribed. It does not recommend a dose. Confirm any result with your prescriber or pharmacist before use.
Sources
- FormBlends Reviews: scoring rubric v1.0 (the eight criteria and their level definitions)
- FormBlends Reviews: conflict of interest disclosure
- FTC: Guides Concerning the Use of Endorsements and Testimonials in Advertising, 16 CFR Part 255 (why there are no user ratings here)
- FDA: Human Drug Compounding (compounded drugs are not FDA approved)
Read before you use it
Guides for this calculator
Questions to ask a GLP-1 program before paying
Twelve questions, one per rubric row and a few more, written so you can paste them into a support chat. What a good answer looks like, what a non-answer looks like, and how to check the answer afterwards.
The scoring rubric: eight criteria, four written levels each
How every evaluation on this site is scored. Eight criteria from licensure to privacy, each scored 0 to 3 against a written definition, from public pages on a stated date. Editorial assessments, not user reviews.
From the FormBlends network
Educational, not medical advice. Read the medical disclaimer.